What is the proper technique and dosing for intralesional triamcinolone acetonide injection in patients with oral lichen planus?

Intralesional Triamcinolone for Oral Lichen Planus

For symptomatic oral lichen planus, inject triamcinolone acetonide 10-40 mg/mL (typically 40 mg/mL) directly into the lesion using 0.5 mL per site at weekly intervals, with most patients requiring 2-6 injections for complete response.

Dosing Protocol

The evidence strongly supports the following approach:

• Concentration: Use triamcinolone acetonide 40 mg/mL suspension 1
• Volume per injection: 0.5 mL per lesion site 1
• Frequency: Weekly injections 2, 1
• Total course: 2-6 injections typically needed 1, 3
• Maximum total dose: Up to 28 mg total per treatment session when treating multiple sites 2

The FDA labeling confirms that for smaller mucosal areas, doses up to 10 mg are usually sufficient, while larger areas may require up to 40 mg 4.

Injection Technique

Critical technical points to ensure safety and efficacy:

1. Strict aseptic technique is mandatory 4
2. Shake the vial thoroughly before drawing to ensure uniform suspension 4
3. Inspect for agglomeration (white precipitate/clumping) - discard if present 4
4. Inject immediately after drawing to prevent settling in the syringe 4
5. Inject submucosally (infralesionally) directly into the lesion base 3
6. Aspirate before injecting to avoid intravascular injection 4, 3
7. Apply antiseptic measures and consider tamponade of salivary orifices 3

Response Assessment

Evaluate treatment response at 2 weeks:

• If ulceration has reduced <81% in size, administer a second injection 1
• Continue weekly injections until complete or near-complete response
• In the 2006 study, 84.4% of patients achieved complete response (complete resolution of ulceration) 1

Enhanced Protocols for Severe Disease

For major erosive lesions that are particularly symptomatic or extensive, consider combination therapy:

• Intralesional triamcinolone acetonide (40 mg weekly for 3 weeks) PLUS
• Oral prednisolone (25-30 mg daily for 2 weeks, then taper over 7 days) 5

This combined approach achieved 90% complete response in major erosive OLP cases within 3 weeks 5. However, note that recurrence occurred in all complete responders after 3-24 months (mean 12 months) 5.

Adjunctive Strategies to Reduce Recurrence

To decrease symptom recurrence, mix hyaluronic acid with triamcinolone:

• Combining HA with triamcinolone reduced recurrence from 74.1% to 11.1% compared to triamcinolone alone 6
• This approach leverages HA's tissue healing, anti-inflammatory, and antioxidant properties 6

Safety Profile

Intralesional triamcinolone demonstrates excellent safety when proper technique is followed:

• No significant complications reported in clinical trials 1
• Minimal adverse effects compared to systemic corticosteroids 7
• Avoid subcutaneous injection as this may cause tissue atrophy 4

Clinical Outcomes

The evidence demonstrates rapid and effective results:

• Pain relief: Rapid reduction in visual analog scale scores within 1 week 1
• Lesion healing: 84-90% complete response rates 1, 5
• Time to response: Most patients show significant improvement within 2-3 weeks 1, 5

Common Pitfalls to Avoid

1. Injecting into surrounding tissue rather than directly into the lesion - this reduces efficacy and increases atrophy risk
2. Using settled suspension - always shake and inject immediately after drawing
3. Stopping too early - continue weekly injections until adequate response, not just symptomatic improvement
4. Intravascular injection - always aspirate before injecting
5. Using agglomerated product - inspect and discard if clumping is present

Maintenance After Initial Response

Following successful intralesional therapy, transition to maintenance with topical corticosteroids (dexamethasone 0.1% mouth rinse or clobetasol 0.05% gel) to prevent recurrence 2, 5. Patients should be counseled that OLP is a chronic condition with potential for recurrence requiring long-term monitoring.